ADMA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ADMA shares is 415, representing 91.4% of the company's common stock.

BOOTHBAY FUND MANAGEMENT, LLC, in the last quarter, reduced its stake in ADMA by -27.8% restricting it's holding to 786.81 thousand shares of worth nearly $5.19M. PEREGRINE CAPITAL MANAGEMENT LLC also lessened -7.69% of the ADMA shares from its portfolio, reducing its holding to 815.04 thousand shares of worth $5.38M. VELAN CAPITAL INVESTMENT MANAGEMENT LP also shunned ADMA shares holding by -28.44% last quarter which brought its holding to 1.53 million shares worth $10.09M.

As per its latest 13F filing, AQR CAPITAL MANAGEMENT LLC increased its stake in ADMA by 38.18% in the last quarter. The institutional holder raised its holding to 816.95 thousand shares having worth more than $5.39M. ALTIUM CAPITAL MANAGEMENT LP also added 40.64% more shares of ADMA to its portfolio, raising its holding to 1.54 million shares of worth $10.16M. VOLORIDGE INVESTMENT MANAGEMENT, LLC also increased its ADMA shares holding by 100% which brought its holding to 1.68 million shares worth $11.08M.

The insider with the most stakes in ADMA is PERCEPTIVE ADVISORS LLC , 10 percent owner at the company. Additionally, ADMA stock is highly held by 10 percent owner Biotest Divestiture Trust and director ELMS STEVE among others.

Company executives, directors, and other insiders own 2.5% percent of ADMA Biologics, Inc.'s stock. Within the last six months, there have been 8 transaction(s) in which ADMA insiders have sold stock, totaling 920.22K shares. Insiders that have sold shares include TADE BRAD L., GROSSMAN ADAM S, and GUIHEEN LAWRENCE P..

There have been 0 transaction(s) during the past 6-months in which ADMA Biologics, Inc. insiders have bought stock, totalling 0 shares

Around 7.62M ADMA Biologics, Inc. shares are held by insiders, which represents about 2.5% of ADMA stock.

ADMA 10 percent owner, PERCEPTIVE ADVISORS LLC holds the largest portfolio of the company's shares. ADMA shares owned by PERCEPTIVE total nearly 13.26 million.

BOOTHBAY FUND MANAGEMENT, LLC is the largest institutional owner in ADMA which holds 786.81 thousand shares worth $5.19M or 0.35% of the total ADMA shares outstanding followed by PEREGRINE CAPITAL MANAGEMENT LLC with ownership of 815.04 thousand shares representing 0.36% of the ADMA ownership. AQR CAPITAL MANAGEMENT LLC is the third largest stakeholder with 816.95 thousand shares or 0.36% of the ownership worth more than $5.39M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ADMA is concerned, it is a stock which is optionable.

Number of ADMA shares short is 13.62M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 236.39M shares of ADMA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ADMA has 232.10M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ADMA is 5.5.